<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: The aim was to estimate the recurrence rate and to define subgroups at increased risk for recurrent <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> in patients with <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo> (<z:mp ids='MP_0004225'>PFO</z:mp>) and so called cryptogenic <z:hpo ids='HP_0001297'>stroke</z:hpo> due to <z:e sem="disease" ids="C0238096" disease_type="Disease or Syndrome" abbrv="">paradoxical embolism</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: <z:hpo ids='HP_0001655'>Patent foramen ovale</z:hpo> was diagnosed in 318 patients with otherwise unexplained ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> or <z:e sem="disease" ids="C0007787" disease_type="Disease or Syndrome" abbrv="tia|TIA|T.I.A.">transient ischaemic attack</z:e> (<z:hpo ids='HP_0002326'>TIA</z:hpo>) </plain></SENT>
<SENT sid="2" pm="."><plain>One hundred and fifty nine were treated medically (oral anticoagulation 79, platelet inhibitors 80) and represent the study population </plain></SENT>
<SENT sid="3" pm="."><plain>The remaining 159 patients underwent endovascular or surgical closure of the <z:mp ids='MP_0004225'>PFO</z:mp> and are not part of this study </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Mean age was 50.7 (SD 13.5) years </plain></SENT>
<SENT sid="5" pm="."><plain>The event leading to the diagnosis of <z:mp ids='MP_0004225'>PFO</z:mp> was a <z:hpo ids='HP_0002326'>TIA</z:hpo> in 38 patients (23.9%), an ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> in 119 (74.8%), and an <z:hpo ids='HP_0100576'>amaurosis fugax</z:hpo> in two patients (1.3%) </plain></SENT>
<SENT sid="6" pm="."><plain>Forty four patients (27.7%) had experienced multiple cerebrovascular ischaemic events before the diagnosis of the <z:mp ids='MP_0004225'>PFO</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>During mean follow up of 29 (SD 23) months 21 patients (13.4%) had a recurrent cerebrovascular event (seven <z:hpo ids='HP_0001297'>strokes</z:hpo> and 14 <z:hpo ids='HP_0002326'>TIAs</z:hpo>) </plain></SENT>
<SENT sid="8" pm="."><plain>The average annual rate of recurrent <z:hpo ids='HP_0001297'>strokes</z:hpo> was 1.8% and that of recurrent <z:hpo ids='HP_0001297'>strokes</z:hpo> or <z:hpo ids='HP_0002326'>TIAs</z:hpo> was 5.5% </plain></SENT>
<SENT sid="9" pm="."><plain>When patients with <z:mp ids='MP_0004225'>PFO</z:mp> with multiple cerebrovascular events before the diagnosis of the <z:mp ids='MP_0004225'>PFO</z:mp> were analyzed separately, the average annual rates of recurrent <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> were 3.6% for recurrent <z:hpo ids='HP_0001297'>strokes</z:hpo> and 9.9% for recurrent <z:hpo ids='HP_0001297'>strokes</z:hpo> or <z:hpo ids='HP_0002326'>TIAs</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>These rates were significantly higher than in patients with first ever <z:hpo ids='HP_0001297'>stroke</z:hpo> or <z:hpo ids='HP_0002326'>TIA</z:hpo> (p=0.02) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: The study confirms a risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> recurrence that is similar to the rates of previously published series of patients with <z:mp ids='MP_0004225'>PFO</z:mp> and cryptogenic <z:hpo ids='HP_0001297'>strokes</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Patients with more than one previous event were at increased risk of recurrent <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> </plain></SENT>
</text></document>